Biogen Inc
NASDAQ: BIIB
$173.04
-$0.88 (-0.5%)
Closing Price on November 8, 2024
BIIB Articles
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
Published:
The Friday afternoon analyst calls were focused on Biogen, 3D Systems, Duke Energy, Ford, and more.
Published:
Tuesday's midday analyst calls included Peloton Interactive, Biogen, Square and Lockheed Martin.
Published:
The November 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
The November 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Published:
These four top stocks offer investors with a longer time horizon solid value and outstanding entry points. They are outstanding ideas for those looking to leave pricier growth companies but wanting...
Published:
Some rather significant changes were made in the Berkshire Hathaway equity portfolio during the third quarter.
Published:
Tuesday's top analyst upgrades and downgrades included AbbVie, Beyond Meat, Biogen, Eli Lilly, Levi Strauss, Nvidia, Pfizer, Plug Power, Raytheon, Square and Wayfair.
Published:
24/7 Wall St. has tracked multiple analyst calls regarding the expected approval or nonapproval of aducanumab as the first viable treatment against Alzheimer's disease.
Published:
Monday's top analyst upgrades and downgrades included Albermarle, Biogen, Fisker, General Motors, Livent, Marriott International, Uber Technologies and Yelp.
Published:
Last Updated:
Thursday's top analyst upgrades and downgrades included Biogen, Honeywell, Microsoft, Ping Identity, Qualcomm, Verizon Communications and Wendy's.
Published:
Biogen shares rocketed up on Wednesday after briefing documents from the FDA provided evidence of the effectiveness of the firm’s Alzheimer’s disease treatment.
Published:
The October 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Tuesday's top analyst upgrades and downgrades included Advanced Micro Devices, Amazon.com, Amgen, Biogen, Hasbro, Kinder Morgan, SAP, Spotify and Twitter.
Published:
Biogen reported better than expected third-quarter financial results with disappointing guidance before the markets opened on Wednesday.
Published: